Medical Supervised Duodenal-Enteral Feeding Treatment

BiomediKcal31 enrolled

Overview

Medical Supervised Duodenal-Enteral Feeding for Overweight, Obesity and Increased Body Fat Percentage Treatment based on an intervention procedure performed by a Licensed Nutritionist Doctor for weight loss and loss of fat percentage in patients who need it. The feeding is by nasogastric-duodenal tube depending on the desired fat loss and / or weight in relation to the basal metabolism. Feeding by tube of 12-29 days, continuing with personalized nutritional treatment for 2 weeks and physical activity during the protocol. Losses of weight and / or expected fat greater than 10%. The results will be compared with bariatric surgery. The main objective is to provide a tool for the obesity epidemic that can be applied worldwide by doctors without the complications of surgery and with a lower price for health systems and controlling the actions of the hormones leptin and ghrelin.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Obesity Obesity, Visceral Overweight and Obesity Body Fat Disorder Feeding and Eating Disorders Hormone Disturbance Weight Loss

Interventions

Nasogastroduodenal ProtocolDIETARY_SUPPLEMENT

Complete nutrition (carbohydrates, lipids, proteins, vitamins, oligoelements)

ControlOTHER

Progress registration of body composition values

Data analysisOTHER

Statistical analysis of all data

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: \- Desire for weight loss, desire to improve body image, voluntariness Exclusion Criteria: \- esophageal alteration or swallowing, not sign the informed consent, acute active disease

Locations (1)

BiomediKcal - Advanced Medical Nutrition & Lifestyle Center

Barranquilla, Atlántico, Colombia

Outcomes

Primary Outcomes

Weightloss

Decrease, minor difference in weight at the end of treatment

Time frame: Change from Baseline weight at 1 and 3 months

Secondary Outcomes

Fat loss

Decrease, minor difference in percentage of fat at the end of treatment

Time frame: Change from Baseline fat percentage at 1 and 3 months

Loss of measures

Decrease of measurements in perimeters (arm, waist, hip, thigh)

Time frame: Change from Baseline measures at 1 and 3 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.